Samah Abd Elhamid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samah Abd Elhamid has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Sherif Mogawer
Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt
4 shared publications G. Saadi
Department of Internal Medicine & Nephrology, Kasr El-Aini, Cairo University, Cairo, Egypt
2 shared publicationsM. El Ansary
Department of Clinical Pathology, Kasr El-Aini, Cairo University, Cairo, Egypt
2 shared publications- Manal Mohamed Makhlouf
Department of Clinical and Chemical Pathology, Faculty of Medicine, Kasr Alainy Hospital, Cairo University, Cairo, Egypt
2 shared publications Mervat El Ansary
Department of Clinical and Chemical Pathological, Faculty of Medicine, Cairo University, Kasr Al-Ainy, Egypt
2 shared publicationsMervat El-Ansary
Clinical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
2 shared publications
Latest Publications
- 28 March 2019
- Published by Springer Nature in Clinical Rheumatology
- Vol. 38 (8) , 2201-2210
Value of hematological indices versus VEGF as biomarkers of activity in Behçet’s disease
The aim of this study is to investigate the value of several hematological indices, neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), red blood cell distribution width (RDW), and mean platelet volume (MPV), versus vascular endothelial growth factor (VEGF) as biomarkers of activity in Behçet’s disease (BD).
- 28 March 2019
- Published by Springer Nature in Clinical Rheumatology
- Vol. 38 (8) , 2201-2210
Value of hematological indices versus VEGF as biomarkers of activity in Behçet’s disease
The aim of this study is to investigate the value of several hematological indices, neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), red blood cell distribution width (RDW), and mean platelet volume (MPV), versus vascular endothelial growth factor (VEGF) as biomarkers of activity in Behçet’s disease (BD).
- Open Access
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 15 (3) , 656-665
Risk index for early infections following living donor liver transplantation
Introduction Post-operative infections in patients undergoing living donor liver transplantation (LDLT) are a major cause of morbidity and mortality. This study aims to develop a practical and efficient prognostic index for early identification and possible prediction of post-transplant...
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 15 (3) , 656-665
Open AccessRisk index for early infections following living donor liver transplantation
Introduction Post-operative infections in patients undergoing living donor liver transplantation (LDLT) are a major cause of morbidity and mortality. This study aims to develop a practical and efficient prognostic index for early identification and possible prediction of post-transplant...
- Open Access
- 1 April 2018
- Published by Elsevier in The Egyptian Rheumatologist
- Vol. 40 (2) , 107-110
Comparing D-dimer status in children with familial Mediterranean fever during and in between acute attacks
- 1 April 2018
- Published by Elsevier in The Egyptian Rheumatologist
- Vol. 40 (2) , 107-110
Open AccessComparing D-dimer status in children with familial Mediterranean fever during and in between acute attacks
- 1 June 2017
- Published by Elsevier in Tissue and Cell
- Vol. 49 (3) , 369-375
Therapeutic efficacy of human umbilical cord mesenchymal stem cells transplantation against renal ischemia/reperfusion injury in rats
- 1 June 2017
- Published by Elsevier in Tissue and Cell
- Vol. 49 (3) , 369-375
Therapeutic efficacy of human umbilical cord mesenchymal stem cells transplantation against renal ischemia/reperfusion injury in rats
- 3 August 2016
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 17 (2) , 117-123
Significance of CD99 expression in T-lineage acute lymphoblastic leukemia
BACKGROUND: CD99 was first isolated as an antigen on the T acute lymphoblastic leukemia cells. It has been shown to participate in T cell adhesion and is widely expressed on a variety of hematopoietic and non-hematopoietic cell types. CD99 was first
- 3 August 2016
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 17 (2) , 117-123
Significance of CD99 expression in T-lineage acute lymphoblastic leukemia
BACKGROUND: CD99 was first isolated as an antigen on the T acute lymphoblastic leukemia cells. It has been shown to participate in T cell adhesion and is widely expressed on a variety of hematopoietic and non-hematopoietic cell types. CD99 was first
- 29 July 2016
- Published by Wiley in Transplant Infectious Disease
- Vol. 18 (4) , 529-537
Prevalence of polyoma BK virus infection among living‐donor renal transplant recipients
Background: Polyomavirus nephropathy (PVN) mainly caused by BK polyomavirus (BKPyV) remains the most common productive viral infection of the kidney in immunosuppressed patients. The diagnosis of PVN is based on the detection of BK viruria and BK viremia in conjunction with histological findings in the graft biopsy.Methods: Our study was aimed to estimate the prevalence of productive BKPyV infection among renal transplant patients within the first year post‐transplant and identify those at risk of developing PVN. Our cross‐sectional study was conducted on 134 kidney transplant patients. Evidence of BKPyV replication was assessed by viral quantification of blood and urine samples of studied patients using a quantitative real‐time polymerase chain reaction (Q‐PCR)PCR), detection of decoy cells in urine cytology smears, histological examination of graft biopsies from Q‐PCR BKPyV‐positive patients, and immunohistochemical staining by simian virus 40 (SV40) antibody.Results: Significant BKPyV infection was prevalent in 8% (n = 11) of our patients, with a peak of BKPyV infection about 8 months post transplant. BKPyV viral load by Q‐PCR assay in these patients varied from 1350 to 20,000,000 (1.35 × 103 to 2 × 107) copies/mL for urine samples and 935 to 18,920 (9.35 × 102 to 1.89 × 104) copies/mL for blood samples. All the 11 patients were positive for decoy cells but only 3 developed PVN based on histology and positive SV40 staining. BKPyV infection was more prevalent in older patients. All patients responded to reduction in their immunosuppressive regimens, apart from 2 patients who required replacement of calcineurin inhibitors‐based regimen with mammalian target of ramapycin inhibitors with an overall good response.Conclusion: Protocol screening programs based on detection of viral replication by viruria, viremia, and decoy cells in urine are necessary to shed light on patients with high virus replication and hence increased risk of developing PVN, and to allow early diagnosis and intervention.
- 29 July 2016
- Published by Wiley in Transplant Infectious Disease
- Vol. 18 (4) , 529-537
Prevalence of polyoma BK virus infection among living‐donor renal transplant recipients
Background: Polyomavirus nephropathy (PVN) mainly caused by BK polyomavirus (BKPyV) remains the most common productive viral infection of the kidney in immunosuppressed patients. The diagnosis of PVN is based on the detection of BK viruria and BK viremia in conjunction with histological findings in the graft biopsy.Methods: Our study was aimed to estimate the prevalence of productive BKPyV infection among renal transplant patients within the first year post‐transplant and identify those at risk of developing PVN. Our cross‐sectional study was conducted on 134 kidney transplant patients. Evidence of BKPyV replication was assessed by viral quantification of blood and urine samples of studied patients using a quantitative real‐time polymerase chain reaction (Q‐PCR)PCR), detection of decoy cells in urine cytology smears, histological examination of graft biopsies from Q‐PCR BKPyV‐positive patients, and immunohistochemical staining by simian virus 40 (SV40) antibody.Results: Significant BKPyV infection was prevalent in 8% (n = 11) of our patients, with a peak of BKPyV infection about 8 months post transplant. BKPyV viral load by Q‐PCR assay in these patients varied from 1350 to 20,000,000 (1.35 × 103 to 2 × 107) copies/mL for urine samples and 935 to 18,920 (9.35 × 102 to 1.89 × 104) copies/mL for blood samples. All the 11 patients were positive for decoy cells but only 3 developed PVN based on histology and positive SV40 staining. BKPyV infection was more prevalent in older patients. All patients responded to reduction in their immunosuppressive regimens, apart from 2 patients who required replacement of calcineurin inhibitors‐based regimen with mammalian target of ramapycin inhibitors with an overall good response.Conclusion: Protocol screening programs based on detection of viral replication by viruria, viremia, and decoy cells in urine are necessary to shed light on patients with high virus replication and hence increased risk of developing PVN, and to allow early diagnosis and intervention.
- Open Access
- 13 June 2015
- Published by Open Access Pub in Journal of Glycomics and Metabolism
- Vol. 1 (1) , 8-24
The role of BCL-2 and BAK genes in chronic kidney disease and haemodialysis patients
- 13 June 2015
- Published by Open Access Pub in Journal of Glycomics and Metabolism
- Vol. 1 (1) , 8-24
Open AccessThe role of BCL-2 and BAK genes in chronic kidney disease and haemodialysis patients
- Open Access
- 1 August 2014
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 45 (3) , 211-219
Expression of IL4 (VNTR intron 3) and IL10 (-627) Genes Polymorphisms in Childhood Immune Thrombocytopenic Purpura
Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder caused by the production of antiplatelet antibodies. These autoantibodies opsonize platelets for splenic clearance, resulting in low levels of circulating platelets. Interleukin 4 (IL4) and interleukin 10 (IL10) are important immunoregulatory cytokines mainly produced by macrophages, monocytes, T cells, B cells, and mast cells. Our study was aimed at detecting the frequency of IL4 (VNTR intron 3) and IL 10 (-627) gene polymorphisms in Egyptian ITP children as genetic markers for ITP risk and clarifying their possible role in the pathogenesis of ITP as well as their correlation with the clinical presentation and laboratory data. IL4 (VNTR intron 3) and IL10 (-627) gene polymorphisms were studied in 70 ITP patients and 50 age- and sex-matched healthy controls using polymerase chain reaction-restriction fragment length polymorphism assay (PCR-RFLP). IL4 RP2 and IL10 A alleles were detected more frequently among ITP patients compared to controls. A statistically significant difference was observed in IL10 and IL4 gene polymorphism distribution between acute and chronic ITP patients, with higher A allele and RP2 allele among chronic ITP patients versus acute ITP patients. Combined polymorphisms of IL4 and IL10 genes were associated with greater risk of ITP. IL4 and IL10 gene polymorphisms may contribute to susceptibility for ITP in children.
- 1 August 2014
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 45 (3) , 211-219
Open AccessExpression of IL4 (VNTR intron 3) and IL10 (-627) Genes Polymorphisms in Childhood Immune Thrombocytopenic Purpura
Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder caused by the production of antiplatelet antibodies. These autoantibodies opsonize platelets for splenic clearance, resulting in low levels of circulating platelets. Interleukin 4 (IL4) and interleukin 10 (IL10) are important immunoregulatory cytokines mainly produced by macrophages, monocytes, T cells, B cells, and mast cells. Our study was aimed at detecting the frequency of IL4 (VNTR intron 3) and IL 10 (-627) gene polymorphisms in Egyptian ITP children as genetic markers for ITP risk and clarifying their possible role in the pathogenesis of ITP as well as their correlation with the clinical presentation and laboratory data. IL4 (VNTR intron 3) and IL10 (-627) gene polymorphisms were studied in 70 ITP patients and 50 age- and sex-matched healthy controls using polymerase chain reaction-restriction fragment length polymorphism assay (PCR-RFLP). IL4 RP2 and IL10 A alleles were detected more frequently among ITP patients compared to controls. A statistically significant difference was observed in IL10 and IL4 gene polymorphism distribution between acute and chronic ITP patients, with higher A allele and RP2 allele among chronic ITP patients versus acute ITP patients. Combined polymorphisms of IL4 and IL10 genes were associated with greater risk of ITP. IL4 and IL10 gene polymorphisms may contribute to susceptibility for ITP in children.
- Open Access
- 27 February 2014
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 28 (4) , 306-309
A Study of Hepcidin and Monocyte Chemoattractant Protein‐1 in Egyptian Females With Systemic Lupus Erythematosus
Background: Lupus nephritis is one of the most serious manifestations of systemic lupus erythematosus (SLE). Novel biomarkers are necessary to enhance the diagnostic accuracy, prognostic stratification, monitoring of treatment response, and detection of early renal flares.Methods: Our study was conducted on 90 participants. They were divided into three groups, group I (controls) encompassed 30 ages and sex‐matched healthy personnel. Group II included 30 non‐nephritic SLE patients and finally group III included 30 SLE nephritic patients. Urinary monocyte chemoattractant protein‐1 (UMCP‐1) and hepcidin were evaluated by ELISA technique, compared and correlated in different groups, with each other and with other routine variables and with renal biopsy done to study group (III).Results: Both UMCP‐1 and hepcidin in group III showed significant increase compared to other two groups (controls and group II) (468 ± 128, 111 ± 12, 252 ± 56 pg/ml, respectively, for UMCP‐1 and 40 ± 12, 11 ± 2, 20 ± 5 ng/ml, respectively, for hepcidin, P < 0.01). Also both UMCP‐1 and hepcidin in group III showed significant increase in diffuse proliferative subgroup compared to focal proliferative and mesangioproliferative subgroups (580 ± 43, 502 ± 46, and 352.6 ± 100 pg/ml, respectively, for UMCP‐1 and 47.8 ± 9.5, 41.4 ± 6, and 32.9 ± 10.8 ng/ml, respectively, for urinary hepcidin, P < 0.05).Conclusion: UMCP‐1 and hepcidin could be associated with the susceptibility of lupus nephritis.
- 27 February 2014
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 28 (4) , 306-309
Open AccessA Study of Hepcidin and Monocyte Chemoattractant Protein‐1 in Egyptian Females With Systemic Lupus Erythematosus
Background: Lupus nephritis is one of the most serious manifestations of systemic lupus erythematosus (SLE). Novel biomarkers are necessary to enhance the diagnostic accuracy, prognostic stratification, monitoring of treatment response, and detection of early renal flares.Methods: Our study was conducted on 90 participants. They were divided into three groups, group I (controls) encompassed 30 ages and sex‐matched healthy personnel. Group II included 30 non‐nephritic SLE patients and finally group III included 30 SLE nephritic patients. Urinary monocyte chemoattractant protein‐1 (UMCP‐1) and hepcidin were evaluated by ELISA technique, compared and correlated in different groups, with each other and with other routine variables and with renal biopsy done to study group (III).Results: Both UMCP‐1 and hepcidin in group III showed significant increase compared to other two groups (controls and group II) (468 ± 128, 111 ± 12, 252 ± 56 pg/ml, respectively, for UMCP‐1 and 40 ± 12, 11 ± 2, 20 ± 5 ng/ml, respectively, for hepcidin, P < 0.01). Also both UMCP‐1 and hepcidin in group III showed significant increase in diffuse proliferative subgroup compared to focal proliferative and mesangioproliferative subgroups (580 ± 43, 502 ± 46, and 352.6 ± 100 pg/ml, respectively, for UMCP‐1 and 47.8 ± 9.5, 41.4 ± 6, and 32.9 ± 10.8 ng/ml, respectively, for urinary hepcidin, P < 0.05).Conclusion: UMCP‐1 and hepcidin could be associated with the susceptibility of lupus nephritis.
- 1 July 2013
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 24 (5) , 525-531
P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting
Platelets have a central role in the pathophysiology of thrombosis. Adenosine diphosphate (ADP) plays a pivotal role as an agonist of platelet activation. Genetic polymorphisms of the P2Y12 ADP receptor might influence the activation of this receptor by ADP or the response of patients to platelet inhibitors. The present study was conducted on a total number of 80 participants, 40 patients were diagnosed with acute coronary syndrome and 40 sex and aged-matched healthy volunteers were included as controls. Platelet aggregation was assessed (before and 1 week after clopidogrel administration) and genotyping of the T744C genetic polymorphism of P2Y12 receptor gene was carried out using the restriction fragment length polymorphism polymerase chain reaction (PCR-RFLP) method. Platelet aggregation of the patients had a range of 54-183% before clopidogrel administration and had a range of 4-113% after its administration. Genotyping of the candidate gene revealed that 72.5% of the patients had a wild allele (TT), whereas 27.5% had a C allele (heterozygous CT, homozygous CC). On the contrary, 97.5% of controls had a wild allele (TT), whereas 2.5% had a C allele (heterozygous CT, homozygous CC). Our study elicited an association between the T744C polymorphism of the P2Y12 ADP receptor gene and platelet reactivity. Carrying the C allele at this position is associated with an increased platelet activation response to ADP.
- 1 July 2013
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 24 (5) , 525-531
P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting
Platelets have a central role in the pathophysiology of thrombosis. Adenosine diphosphate (ADP) plays a pivotal role as an agonist of platelet activation. Genetic polymorphisms of the P2Y12 ADP receptor might influence the activation of this receptor by ADP or the response of patients to platelet inhibitors. The present study was conducted on a total number of 80 participants, 40 patients were diagnosed with acute coronary syndrome and 40 sex and aged-matched healthy volunteers were included as controls. Platelet aggregation was assessed (before and 1 week after clopidogrel administration) and genotyping of the T744C genetic polymorphism of P2Y12 receptor gene was carried out using the restriction fragment length polymorphism polymerase chain reaction (PCR-RFLP) method. Platelet aggregation of the patients had a range of 54-183% before clopidogrel administration and had a range of 4-113% after its administration. Genotyping of the candidate gene revealed that 72.5% of the patients had a wild allele (TT), whereas 27.5% had a C allele (heterozygous CT, homozygous CC). On the contrary, 97.5% of controls had a wild allele (TT), whereas 2.5% had a C allele (heterozygous CT, homozygous CC). Our study elicited an association between the T744C polymorphism of the P2Y12 ADP receptor gene and platelet reactivity. Carrying the C allele at this position is associated with an increased platelet activation response to ADP.